|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.05 INR | +4.14% |
|
+8.44% | +35.46% |
Aristo Bio-Tech and Lifescience Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 1,911.66 million compared to INR 1,960.65 million a year ago. Revenue was INR 1,660.33 million compared to INR 1,672.3 million a year ago.
Net income was INR 14.5 million compared to INR 10.76 million a year ago. Basic earnings per share from continuing operations was INR 2.9 compared to INR 2.15 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.46% | 6.89M | |
| -11.39% | 3.17B | |
| -38.29% | 1.69B | |
| -16.07% | 1.55B | |
| -16.89% | 1.45B | |
| -10.73% | 1.17B | |
| -9.32% | 1.05B | |
| -33.08% | 908M | |
| +58.49% | 907M | |
| -17.93% | 876M |
ARISTO BIO-TECH AND LIFESCIENCE LIMITED 
